Research

Clinical Trials; Research

Fluorescent Nanoprobe Produces ‘Breakthrough’ for Peritoneal Metastases

November 15, 2023

Latest

Therapeutic Targeting of Septin Proteins: A New Pan-Cancer Focus?

October 25, 2023

Preventing Lineage Plasticity in Prostate Cancer Cells Resensitizes Them to Therapy

May 3, 2023

Novel Biomarker-Guided Therapeutics Target Glioma Origins

April 5, 2023

Targeting Lactate Metabolism for Cancer Immunotherapy

March 29, 2023

Grants Awarded to Expand Clinical Trials Navigation

March 22, 2023

New Nanotechnology Allows Tissue-Specific Delivery of Genomic Medicines

Researchers are combining experience in chemical synthesis and nanoparticle engineering with their knowledge of cancer development to design future therapies.

April 30, 2021

Lung Cancer; Research

AXL Inhibition Restores Response to PD-1 Blockade in STK11/LKB1-mutant NSCLC

New Simmons Cancer Center research involving investigational drug to target AXL inhibition shows possible benefits for patients with lung adenocarcinomas.

August 15, 2022

Genitourinary Cancer; Research

ChIA-PET Sequencing Provides Insight into Prostate Cancer Genomics

Leveraging chIA-PET sequencing, researchers at UT Southwestern have discovered findings that could lead to novel prostate cancer therapies. Learn more here.

April 29, 2021

Gastrointestinal Cancer; Research

Adjuvant Chemotherapy for Stage III Colon Cancer in Healthy Patients

Researchers at UT Southwestern set out to understand the under-utilization of ACT in stage three colon cancer patients. Learn the impact on patient outcomes here.

September 18, 2020

All Articles